Regulation Microvascular Smooth Muscle Ca2+ & BK+ ECM-Integrin-Cytoskeletal Axis

调节微血管平滑肌 Ca2

基本信息

  • 批准号:
    7918615
  • 负责人:
  • 金额:
    $ 41.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-03-22 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

Interactions between vascular integrins and ECM components of the blood vessel wall are important determinants of arteriolar tone and blood flow control. In Project 2, we focus on two aspects of vascular function in which ECM-integrin interactions acutely regulate vascular tone: 1) mechanotransduction of intravascular pressure through voltage-gated, L-type Ca^* channels (CBL) and BK (large-conductance calcium-activated K*) channels, and 2) the effects of biologically active matricryptins (i.e., proteolytic fragments of ECM proteins with vasoactive properties). The central hvpothesis of Project 2 is that a5B1 inteqrin plavs a critical role in mediatinq the transduction of physiological stretch to mVSM ion channels to enhance mvoqenic tone, while avB3 inteqrin functions as a matricryptin receptor to inhibit myoqenic tone and initiate vasodilation in response to vessel wall iniurv. The hypothesis will be tested using patch-clamp methods to record CaL and BK (large-conductance calcium-activated K* channel) currents in single rat or mouse mVSM cells and diameter responses of isolated arterioles in conjunction with adenoviral methods to manipulate the expression of selected proteins in arteriolar smooth muscle. There are two specific aims Aim A will focus on how longitudinal cell stretch is transduced through integrins to potentiate CBL and BK channels and myogenic tone. We predict that: aSpi integrin but not avp3 integrin transduces mechanical force to regulate CBL and BK channels; talin-1, paxillin, a-actinin and p130Cas are critical focal adhesion proteins required for force transmission through integrins to VSM channels; stretch-induced potentiation of by integrin-linked kinases and phosphatases. Aim B will focus on how avpS integrin functions as a matricryptin receptor to inhibit myogenic tone. We predict that: fibronectin, osteopontin and collagen contain matricryptic sites that induce arteriolar dilatation; matricryptins act by inhibition of mVSM CaL channels and/or activation of BK channels; matricryptin-induced signaling through avpS integrin is mediated by phosphorylation of the p3 integrin tail by Src. The studies will expand our knowledge of how physiologic stretch regulates key VSM ion channels and how proteolytic fragments of ECM proteins exert their vasoactive effects.
血管整合素和血管壁ECM成分之间的相互作用是重要的 小动脉张力和血流控制的决定因素。在项目2中,我们关注ECM-整合素相互作用急性调节血管张力的血管功能的两个方面:1)通过电压门控L型Ca^* 通道(CBL)和BK(大电导钙激活K*)通道的血管内压力的机械转导,以及2)生物活性基质隐蛋白(即,具有血管活性特性的ECM蛋白的蛋白水解片段)。项目2的中心假设是α 5 β 1介导生理牵张传导至mVSM离子通道以增强血管紧张性,而α v β 3介导作为基质蛋白受体以抑制血管紧张性并启动血管舒张以响应血管壁损伤。将使用膜片钳方法记录单个大鼠或小鼠mVSM细胞中的CaL和BK(大电导钙激活K* 通道)电流以及分离的小动脉的直径反应,结合腺病毒方法来操纵小动脉平滑肌中选定蛋白质的表达,从而对该假设进行检验。有两个具体的目标,目标A将集中在纵向细胞拉伸是如何通过整合素转导,以加强CBL和BK通道和肌源性紧张。我们预测:α Spi整联蛋白而不是α ν β 3整联蛋白转导机械力以调节CBL和BK通道; talin-1、桩蛋白、α-辅肌动蛋白和p130 Cas是通过整联蛋白向VSM通道传递力所需的关键粘着斑蛋白;牵张诱导的整联蛋白连接的激酶和磷酸酶的增强作用。目的B将关注avpS整合素如何作为基质密码蛋白受体抑制肌源性张力。我们预测:纤连蛋白、骨桥蛋白和胶原蛋白含有诱导小动脉扩张的基质密合位点;基质密合蛋白通过抑制mVSM CaL通道和/或激活BK通道起作用;基质密合蛋白诱导的通过α v β S整联蛋白的信号传导由Src对β 3整联蛋白尾部的磷酸化介导。这些研究将扩大我们对生理牵张如何调节关键VSM离子通道以及ECM蛋白的蛋白水解片段如何发挥其血管活性作用的认识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael John Davis其他文献

Michael John Davis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael John Davis', 18)}}的其他基金

KATP channels and lymphatic dysfunction in Cantu Syndrome
坎图综合征中的 KATP 通道和淋巴功能障碍
  • 批准号:
    10229489
  • 财政年份:
    2018
  • 资助金额:
    $ 41.5万
  • 项目类别:
KATP channels and lymphatic dysfunction in Cantu Syndrome
坎图综合征中的 KATP 通道和淋巴功能障碍
  • 批准号:
    10021021
  • 财政年份:
    2018
  • 资助金额:
    $ 41.5万
  • 项目类别:
Lymphatic pacemaking and pumping in lymphedema: function, dysfunction, and rescue
淋巴水肿中的淋巴起搏和泵送:功能、功能障碍和救援
  • 批准号:
    10533796
  • 财政年份:
    2015
  • 资助金额:
    $ 41.5万
  • 项目类别:
Lymphatic pacemaking and pumping in lymphedema: function, dysfunction, and rescue
淋巴水肿中的淋巴起搏和泵送:功能、功能障碍和救援
  • 批准号:
    10360550
  • 财政年份:
    2015
  • 资助金额:
    $ 41.5万
  • 项目类别:
Lymphatic pacemaking and pumping in lymphedema: function, dysfunction, and rescue
淋巴水肿中的淋巴起搏和泵送:功能、功能障碍和救援
  • 批准号:
    8882898
  • 财政年份:
    2015
  • 资助金额:
    $ 41.5万
  • 项目类别:
Lymphatic pacemaking and pumping in lymphedema: function, dysfunction, and rescue
淋巴水肿中的淋巴起搏和泵送:功能、功能障碍和救援
  • 批准号:
    9887669
  • 财政年份:
    2015
  • 资助金额:
    $ 41.5万
  • 项目类别:
Conduction and coordination of electrical signals within the lymphatic vascular wall
淋巴管壁内电信号的传导和协调
  • 批准号:
    9188827
  • 财政年份:
    2014
  • 资助金额:
    $ 41.5万
  • 项目类别:
Mechanisms of lymphatic valve and pump dysfunction in lymphedema
淋巴水肿中淋巴瓣和淋巴泵功能障碍的机制
  • 批准号:
    8898205
  • 财政年份:
    2014
  • 资助金额:
    $ 41.5万
  • 项目类别:
Mechanisms of lymphatic valve and pump dysfunction in lymphedema
淋巴水肿中淋巴瓣和淋巴泵功能障碍的机制
  • 批准号:
    9113678
  • 财政年份:
    2014
  • 资助金额:
    $ 41.5万
  • 项目类别:
Conduction and coordination of electrical signals within the lymphatic vascular wall
淋巴管壁内电信号的传导和协调
  • 批准号:
    9393354
  • 财政年份:
    2014
  • 资助金额:
    $ 41.5万
  • 项目类别:

相似海外基金

How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y004841/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.5万
  • 项目类别:
    Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
  • 批准号:
    BB/Y001427/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.5万
  • 项目类别:
    Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
  • 批准号:
    BB/Y005414/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.5万
  • 项目类别:
    Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
  • 批准号:
    10669829
  • 财政年份:
    2023
  • 资助金额:
    $ 41.5万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10587090
  • 财政年份:
    2023
  • 资助金额:
    $ 41.5万
  • 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
  • 批准号:
    10821599
  • 财政年份:
    2023
  • 资助金额:
    $ 41.5万
  • 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
  • 批准号:
    10841832
  • 财政年份:
    2023
  • 资助金额:
    $ 41.5万
  • 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
  • 批准号:
    10532480
  • 财政年份:
    2022
  • 资助金额:
    $ 41.5万
  • 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
  • 批准号:
    10741261
  • 财政年份:
    2022
  • 资助金额:
    $ 41.5万
  • 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
  • 批准号:
    10674894
  • 财政年份:
    2022
  • 资助金额:
    $ 41.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了